Dermatol Surg 2017 Jun;43(6):798-804
*Weill Cornell/New York Presbyterian, Division of Dermatology, New York, New York; †Memorial Sloan Kettering Cancer Center, Dermatology Service, New York, New York; ‡Memorial Sloan Kettering Cancer Center, Department of Pathology, New York, New York.
: Clinical and dermatoscopic guidelines are used to differentiate between benign longitudinal melanonychia (LM) and subungual melanoma; however, the frequency of malignancy among patients undergoing a biopsy for LM is not well defined.Objective
: To describe the histologic diagnoses and malignancy among patients undergoing a biopsy for clinical LM.Methods
: Retrospective cohort study of consecutive patients who underwent a nail biopsy for LM at a single cancer center between 2000 and 2014. Read More